In a recent piece from Psychology Today, tardive dyskinesia (TD) is brought into sharper public awareness as both a prevalent and often underdiagnosed condition linked to antipsychotic use. The article explores the need for more consistent screening practices and highlights how AI-powered tools, like Videra Health’s TDScreen, are improving early detection and access to care. It also stresses the physical, emotional, and social burden TD places on individuals, and how timely intervention can significantly reduce its impact. With advanced screening technology and FDA-approved treatments, the future of TD care is shifting from reactive to proactive. Read the full article here.